about
Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty.Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry studyDiscrepancies between cardiovascular magnetic resonance and Doppler echocardiography in the measurement of transvalvular gradient in aortic stenosis: the effect of flow vorticity.Non-invasive determination of left ventricular workload in patients with aortic stenosis using magnetic resonance imaging and Doppler echocardiography.Usefulness of global left ventricular longitudinal strain for risk stratification in low ejection fraction, low-gradient aortic stenosis: results from the multicenter True or Pseudo-Severe Aortic Stenosis study.A Systematic Review of Mitral Valve Repair With Autologous Pericardial Leaflet Augmentation for Rheumatic Mitral Regurgitation.Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies.Circulating levels of matrix gla protein and progression of aortic stenosis: a substudy of the Aortic Stenosis Progression Observation: Measuring Effects of rosuvastatin (ASTRONOMER) trial.Mitral valve repair and subvalvular intervention for secondary mitral regurgitation: a systematic review and meta-analysis of randomized controlled and propensity matched studies.Multimodality imaging assessment of mitral valve anatomy in planning for mitral valve repair in secondary mitral regurgitation.Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy.Echocardiographic predictors of outcomes in adults with aortic stenosis.Evolution and prognostic impact of low flow after transcatheter aortic valve replacement.Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.Impact of classic and paradoxical low flow on survival after aortic valve replacement for severe aortic stenosis.Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis.Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study.New insights into mitral valve dystrophy: a Filamin-A genotype-phenotype and outcome study.Impact of cardiac resynchronization therapy on mitral valve apparatus geometry and clinical outcomes in patients with secondary mitral regurgitation.Deleterious variants in DCHS1 are prevalent in sporadic cases of mitral valve prolapse.Effects of cardiac resynchronization therapy after inferior myocardial infarction on secondary mitral regurgitation and mitral valve geometry.Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study.Relationship Between Proximal Aorta Morphology and Progression Rate of Aortic Stenosis.ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis: A Substudy of the TOPAS Study.Mitral Valve and Subvalvular Repair for Secondary Mitral Regurgitation: Rationale and Clinical Outcomes of the Papillary Muscle Sling.Discordant Grading of Aortic Stenosis Severity: Echocardiographic Predictors of Survival Benefit Associated With Aortic Valve Replacement.Relationship Between Insulin-Like Growth Factor Binding Protein-2 and Left Ventricular Stroke Volume in Patients With Aortic Stenosis.Circulating Lp-PLA2 is associated with high valvuloarterial impedance and low arterial compliance in patients with aortic valve bioprostheses.Combined papillary muscle sling and ring annuloplasty for moderate-to-severe secondary mitral regurgitation.Visceral adiposity and left ventricular mass and function in patients with aortic stenosis: the PROGRESSA study.Assessment of Aortic Valve Disease: Role of Imaging Modalities.Myocardial injury following transcatheter aortic valve implantation: insights from delayed-enhancement cardiovascular magnetic resonance.Tricuspid Regurgitation Is Associated With Increased Risk of Mortality in Patients With Low-Flow Low-Gradient Aortic Stenosis and Reduced Ejection Fraction: Results of the Multicenter TOPAS Study (True or Pseudo-Severe Aortic Stenosis).Therapy for secondary mitral regurgitation: time to 'cut the chord'?Normalized left ventricular workload using phase-contrast magnetic resonance imaging in patients with aortic stenosis.Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study.A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis.Progression of Hypertrophy and Myocardial Fibrosis in Aortic Stenosis: A Multicenter Cardiac Magnetic Resonance Study.
P50
Q30275622-47564884-ABC1-4B13-B030-93B92EA34C58Q35338051-603BAC33-A5B2-46B5-AFA2-184A7496F679Q37359996-EC23350A-5635-483A-A9DA-E016DAF5F79AQ37525457-73EEA6D0-688A-4BE1-8B44-ECD4C14DF8C4Q38416274-1200F9D8-6BDF-4D42-B808-478BE4D8AC5CQ38869851-8068CB15-C84F-4D21-ABBC-74796C34492DQ39123987-68A98BA0-BC18-486E-A0F9-8DC1C9547209Q39160958-42093B1F-5255-4FAE-A42A-E6B630B2E0A6Q39455985-0184168D-1E78-4C2D-B52B-07596D48A6A4Q39456015-89391412-DCBC-4BB3-898B-52123B6BDE0DQ39587019-8C21F564-A755-460D-95AC-56812031DFBDQ40816058-3BCDB7DA-8F86-4FDB-842F-696C93814029Q40913168-FAE1B495-1C2C-41A6-9467-B297F03F7B79Q43455656-F1F5049D-D093-4617-9E96-2135F8019F87Q43460539-92B0A0B3-37D3-4D9A-9483-C5BA7E34F17CQ44322817-55A6A88F-F2FB-4E8D-9D66-C467507CF53DQ45055180-E54D767C-F536-45AB-A25D-5676D0F11C53Q45991343-18555EA7-435C-4EEE-8E9A-23E05A80F27BQ46808997-CB782CD0-D439-4694-B0ED-AA3A06051408Q47686378-173D08E0-C571-4AB3-ADBE-961727C273C6Q47806929-B1A4C193-AE6D-45BD-B5CF-51B9CED2B580Q48149024-0C7BE22B-9E45-432F-B6CC-6140DF6DBDE9Q49215602-5753E018-89F8-42C2-8D33-330D2661D3DAQ49887432-9EA09167-3F67-448F-83AC-4216417C797DQ50027863-A5F0657F-7A0F-41F6-B061-4D184DFF9BCAQ50057892-B67984CC-740B-4C93-93F1-B0B7F423288AQ50067615-9DACEADA-4A12-4CC7-9457-0641DCBBA5CBQ50641134-B860CC5A-1D9F-4E1B-8FFD-D051B7362C7DQ50871198-8902645F-9CD3-47DC-9976-2E62D4B3E923Q51550702-CE3302C6-8FB2-4B9D-9BE4-11A42B91BED4Q51739633-1DA8FB18-C3FF-4FE8-A8AB-9E0E787DD9E0Q53061449-F0C2315F-D9D2-4010-8D33-3A8073C88816Q53337641-9A30999F-9B24-4F0B-B974-04D351867EFCQ53461097-9AF13FE9-2D04-48E5-AB2F-BB3CB72E9A4EQ53563285-015C4D73-089C-42F7-831A-584C3F80D44BQ53566303-0987C970-49D9-43AE-A40F-58030003B5CBQ53649866-3E28712E-593A-4584-A130-34C75FAA57CAQ53671090-EA3517CA-04E8-4A29-8044-E01627522947Q55397776-0CF2478C-4BD1-42CC-9D87-30188370A76FQ55661595-175B5975-6788-46F1-9A3F-6F3A11BA9B44
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Romain Capoulade
@ast
Romain Capoulade
@en
Romain Capoulade
@es
Romain Capoulade
@nl
Romain Capoulade
@sl
type
label
Romain Capoulade
@ast
Romain Capoulade
@en
Romain Capoulade
@es
Romain Capoulade
@nl
Romain Capoulade
@sl
prefLabel
Romain Capoulade
@ast
Romain Capoulade
@en
Romain Capoulade
@es
Romain Capoulade
@nl
Romain Capoulade
@sl
P108
P106
P31
P496
0000-0002-7233-7409